This finding could aid the HIV vaccine research field.
July 19, 2017
____________________________________________________________________________________
____________________________________________________________________________________
A natural immune system process that protects against autoimmune
disease apparently prevents the body from developing antibodies that can
thwart HIV. This finding could contribute to the field of HIV vaccine
research.
Publishing their findings in The Journal of
Experimental Medicine, researchers studied mice engineered to have
genetic defects leading to symptoms similar to the autoimmune disease
lupus.
The researchers infected the mice with HIV and
injected them with a chemical called alum that is often used in
vaccinations because it prompts the secretion of antibodies. These mice
produced antibodies that could neutralize the virus.
Next,
the scientists gave mice without such engineering a drug that
suppressed a process known as immunological tolerance, in which the body
prevents the creation of autoimmune-causing antibodies. Infected with
HIV, these mice also produced antibodies that could neutralize the
virus. Alum injections prompted higher levels of these antibodies.
Additionally, when the mice were injected with an HIV protein known as
Env, they produced broadly neutralizing antibodies that have the
capacity to neutralize a wide variety of HIV strains.
A
major question for further research is whether an HIV vaccine method
could temporarily relax the body’s line of defense against autoimmune
conditions without leading to autoimmune-related damage.
To read a press release about the study, click here.
To read the study, click here.
Read more articles from POZ, here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.